Bronchiectasis is a chronic lung disease characterized by persistent, irreversible dilation of the bronchial airways with impaired mucociliary clearance. It is associated with recurrent infection, mucus retention, chronic cough, and progressive respiratory morbidity.
The FDA has expanded approval of GSK's Arexvy RSV vaccine to include adults aged 18 to 49 years at increased risk for lower respiratory tract disease, based on phase 3b trial data showing noninferior immune response.
Zydus Lifesciences received USFDA final approval for 32 mg bosentan tablets for pediatric PAH and Ammonium Lactate Cream, 12%, while launching an affordable respiratory device in India.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07599969 |
Bronchiectasis Phenotype Identification Model |
RECRUITING | |
| NCT07599839 |
BASE: Bronchiectasis Severity and Exacerbation Risk Study |
RECRUITING | |
| NCT07577804 |
A Study to Evaluate the Efficacy and Safety of CHF10196 Tablets (Florensocatib) Compared With Placebo in Male and Female Participants 12 to 85 Years of Age With Bronchiectasis |
NOT_YET_RECRUITING | PHASE3 |
| NCT07539571 |
Telerehabilitation in Patients With Bronchiectasis |
NOT_YET_RECRUITING | NA |
| NCT07523165 |
Efficacy and Safety of Lifei Qingchang Granules for Stable Bronchiectasis |
NOT_YET_RECRUITING | PHASE2 |
| NCT07493629 |
Immune Status and Disease Control of Inflammatory Airway Diseases |
RECRUITING | |
| NCT07490704 |
Clinical Outcomes of BronchiEctaSis in Taiwan: A Multicenter Prospective Cohort (BEST Study) |
ACTIVE_NOT_RECRUITING | |
| NCT07443124 |
Simeox 200 US Study |
NOT_YET_RECRUITING | NA |
| NCT07313904 |
Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and Bronchiectasis |
RECRUITING | |
| NCT07291167 |
Study on the Correlation Between Metabolomics and Anxiety and Depression in Bronchiectasis |
NOT_YET_RECRUITING |
